Correlation Between EFFECTOR Therapeutics and Celularity
Can any of the company-specific risk be diversified away by investing in both EFFECTOR Therapeutics and Celularity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EFFECTOR Therapeutics and Celularity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EFFECTOR Therapeutics and Celularity, you can compare the effects of market volatilities on EFFECTOR Therapeutics and Celularity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EFFECTOR Therapeutics with a short position of Celularity. Check out your portfolio center. Please also check ongoing floating volatility patterns of EFFECTOR Therapeutics and Celularity.
Diversification Opportunities for EFFECTOR Therapeutics and Celularity
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between EFFECTOR and Celularity is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding EFFECTOR Therapeutics and Celularity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celularity and EFFECTOR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EFFECTOR Therapeutics are associated (or correlated) with Celularity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celularity has no effect on the direction of EFFECTOR Therapeutics i.e., EFFECTOR Therapeutics and Celularity go up and down completely randomly.
Pair Corralation between EFFECTOR Therapeutics and Celularity
Assuming the 90 days horizon EFFECTOR Therapeutics is expected to generate 3.09 times more return on investment than Celularity. However, EFFECTOR Therapeutics is 3.09 times more volatile than Celularity. It trades about 0.01 of its potential returns per unit of risk. Celularity is currently generating about 0.01 per unit of risk. If you would invest 18.00 in EFFECTOR Therapeutics on September 1, 2024 and sell it today you would lose (17.90) from holding EFFECTOR Therapeutics or give up 99.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 38.3% |
| Values | Daily Returns |
EFFECTOR Therapeutics vs. Celularity
Performance |
| Timeline |
| EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Celularity |
EFFECTOR Therapeutics and Celularity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with EFFECTOR Therapeutics and Celularity
The main advantage of trading using opposite EFFECTOR Therapeutics and Celularity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EFFECTOR Therapeutics position performs unexpectedly, Celularity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will offset losses from the drop in Celularity's long position.| EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
| Celularity vs. Immix Biopharma | Celularity vs. ZyVersa Therapeutics | Celularity vs. Hepion Pharmaceuticals | Celularity vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |